Cross-tolerance between spinal neostigmine and morphine in the rat

British Journal of Anaesthesia

Volumn 91, Issue 3, 2003, Pages 427-429

  Dunbar, Stuart A ^a   Karamian, I G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaesthetic techniques, subarachnoid; Analgesics opioid, morphine; Antagonists neuromuscular block, neostigmine

Indexed keywords

MORPHINE; NEOSTIGMINE; SODIUM CHLORIDE;

ANTINOCICEPTION; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG MECHANISM; DRUG POTENCY; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA;

EID: 0042329267     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg187     Document Type: Article

References (13)

1. Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 1997; 85: 847-53
2. Buckley GA, Heading CE, Moradian MH. Tolerance to neostigmine in rodents and its prevention by cycloheximide treatment. J Pharm Pharmacol 1978; 30: 332-4
3. Russell RW, Overstreet DH, Cotman CW, et al. Experimental tests of hypotheses about neurochemical mechanisms underlying behavioral tolerance to the anticholinesterase, diisopropyl fluorophosphate. J Pharmacol Exp Ther 1975; 192: 73-85
4. Yaksh TL, Grafe MR, Malkmus S, et al. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 1995; 82: 412-27
5. Wong CL, Bentley GA. The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice. Eur J Pharmacol 1980; 61: 99-109
6. Costa LG, Murphy SD. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine. Neurobehav Toxicol Teratol 1985; 7: 251-6
7. Dunbar SA, Yaksh TL. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996; 84: 1177-88
8. Tallurida RJ, Murray RB. Manual of Pharmacologic Calculations and Computer Programs. New York: Springer-Verlag, 1981
9. Ellis JL, Harman D, Gonzalez J, et al. Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype. J Pharmacol Exp Ther 1999; 288: 1143-50
10. Iwamoto ET, Marion L. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J Pharmacol Exp Ther 1994; 271: 601-8
11. Powell KJ, Hosokawa A, Bell A, et al. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal oploid tolerance. Br J Pharmacolol 1999; 127: 631-44
12. Klimscha W, Tong C, Eisenach JC. Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology 1997; 87: 110-6
13. Dirksen R, Nijhuis GM. The relevance of cholinergic transmission at the spinal level to opiate effectiveness. Eur J Pharmacol 1983; 91: 215-21